BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31046104)

  • 1. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML
    JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.
    Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
    Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
    J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
    Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
    J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.
    Smith EM; Ritchie JM; Summersgill KF; Klussmann JP; Lee JH; Wang D; Haugen TH; Turek LP
    Int J Cancer; 2004 Feb; 108(5):766-72. PubMed ID: 14696105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of oral HPV infection in the United States, 2009-2010.
    Gillison ML; Broutian T; Pickard RK; Tong ZY; Xiao W; Kahle L; Graubard BI; Chaturvedi AK
    JAMA; 2012 Feb; 307(7):693-703. PubMed ID: 22282321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia.
    Quintero K; Giraldo GA; Uribe ML; Baena A; Lopez C; Alvarez E; Sanchez GI
    Braz J Otorhinolaryngol; 2013; 79(3):375-81. PubMed ID: 23743755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx].
    Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A
    Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
    Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
    Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
    Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
    Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
    Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M
    Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma.
    Agrawal Y; Koch WM; Xiao W; Westra WH; Trivett AL; Symer DE; Gillison ML
    Clin Cancer Res; 2008 Nov; 14(21):7143-50. PubMed ID: 18981014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
    Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
    BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults.
    Jamieson LM; Antonsson A; Garvey G; Ju X; Smith M; Logan RM; Johnson NW; Hedges J; Sethi S; Dunbar T; Leane C; Hill I; Brown A; Roder D; De Souza M; Canfell K
    JAMA Netw Open; 2020 Jun; 3(6):e204951. PubMed ID: 32511719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
    Das LC; Karrison TG; Witt ME; Muller C; Stenson K; Blair EA; Cohen EEW; Seiwert TY; Haraf DJ; Vokes EE
    Ann Oncol; 2015 Jan; 26(1):198-205. PubMed ID: 25361984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.